MKI67 and breast carcinoma: We first studied the expression profile and cellular localisation of Ki-67 in different cells, namely in non-cancerous primary human dermal fibroblasts (HDF) and human umbilical vein endothelial cells (HUVEC), as well as in human breast cancer cells (MDA-MB-231), human cervix adenocarcinoma cells (HeLa), and hypopharyngeal carcinoma cells (FaDu).